Natco Pharma’s wholly-owned subsidiary (WOS) -- NATCO Pharma Asia has acquired 49% of shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. The company already owns 51% of PT NATCO Lotus Farma. Post this acquisition, the company along with its WOS wholly-owns 100% of PT NATCO Lotus Farma.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
